The company expects to begin trading on the CSE by July 7, provided it finalizes a US$310,000 funding agreement with Lind Global Fund III LP. This transition is part of a broader restructuring effort that includes settling $207,000 in debt through the issuance of common shares at a post-consolidated price of $0.15 each. These steps remain subject to final regulatory filings and standard listing conditions.

Else Nutrition, known for its plant-based, non-dairy infant and toddler formulas, has built its market presence on a portfolio of whole-food ingredients like buckwheat and almonds. Despite achieving significant retail traction and securing various industry accolades—including multiple Amazon best-seller rankings—the company is currently navigating the complexities of its exchange migration. Management maintains that these corporate maneuvers are essential for the next phase of its international expansion.